Literature DB >> 6601898

Open trial of cimetidine in the prevention of upper gastro-intestinal haemorrhage in patients with severe intracranial injury.

E Mouawad, T Deloof, F Genette, A Vandesteene.   

Abstract

The present study evaluates the efficacy of Cimetidine in the prevention of clinically important gastro-intestinal haemorrhage in patients suffering from severe head injury. Fifty patients (39 males and 11 females) were included in the study. We excluded from the trial patients on anticoagulant therapy or concomitant non-steroid anti-inflammatory agents, pregnant and lactating women, and patients with previous histories of peptic ulcer disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601898     DOI: 10.1007/bf01401425

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  5 in total

1.  Prospective study of gastric secretion in stressed patients with intracranial injury.

Authors:  F Idjadi; R Robbins; W M Stahl; G Essiet
Journal:  J Trauma       Date:  1971-08

2.  Effects of an anticholinergic drug on gastric acid secretion in the comatose patient.

Authors:  C Watts; K Clark
Journal:  Surg Gynecol Obstet       Date:  1970-01

3.  Gastric acidity in the comatose patient.

Authors:  C C Watts; K Clark
Journal:  J Neurosurg       Date:  1969-02       Impact factor: 5.115

4.  Gastrointestinal bleeding following head injury: a clinical study of 433 cases.

Authors:  T Kamada; H Fusamoto; S Kawano; M Noguchi; K Hiramatsu
Journal:  J Trauma       Date:  1977-01

5.  Prevention of acute gastrointestinal complications after severe head injury: a controlled trial of cimetidine prophylaxis.

Authors:  L G Halloran; A M Zfass; W E Gayle; C B Wheeler; J D Miller
Journal:  Am J Surg       Date:  1980-01       Impact factor: 2.565

  5 in total
  1 in total

1.  Stress ulcer prophylaxis in trauma patients.

Authors:  Jeffrey F Barletta; Brian L Erstad; John B Fortune
Journal:  Crit Care       Date:  2002-09-25       Impact factor: 9.097

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.